Figure 2From: Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial Impact of E.coli autovaccine on exhaled NO as marker of bronchial inflammation in house dust mite allergic asthma. Figure 2 illustrates the increase of exhaled nitric oxide under specific bronchial challenge before and after autovaccine applicationBack to article page